Previous Close | 0.6250 |
Open | 0.5950 |
Bid | 0.6250 x N/A |
Ask | 0.6500 x N/A |
Day's Range | 0.5950 - 0.5950 |
52 Week Range | 0.5950 - 6.5000 |
Volume | |
Avg. Volume | 0 |
Market Cap | 22.746M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
With me on the line today is Glenn Mattes, president and CEO of TFF; Kirk Coleman, chief financial officer; Dr. Dale Christensen, TFF's director of clinical development; Dr. The press release announcing our second quarter results is available on the TFF Pharmaceuticals website.
TFF Pharmaceuticals, Inc. ( NASDAQ:TFFP ) is possibly approaching a major achievement in its business, so we would like...